109 results
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
8 May 24
Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
4:04pm
Details:
U.S./Toll-Free: +1 833 470 1428
International: +1 404 975 4839
Passcode: 479107
You may also access the call via webcast by visiting
8-K
EX-99.1
rpyb6ugr 8mgvjlvs
28 Feb 24
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
tu5i9zv 0x0
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
8-K
EX-99.2
dsc90e
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
8-K
EX-99.1
6mnox
2 Nov 23
Results of Operations and Financial Condition
4:06pm
8-K
EX-99.1
thdc4jqlkdq3
13 Oct 23
Other Events
4:16pm
8-K
EX-99.1
k8diahn
5 Sep 23
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics
8:36am
8-K
EX-10.1
b3nrmqb7vj0w78a
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.1
qcysfrf
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-10.2
z1mzyy
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
b20bkxb
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.2
4qcvt7pcyc59w9jx
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am